Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

Karin Rosén joined  Horizon Therapeutics plc (NASDAQ:HZNP) as CSO and EVP, research and development. She was SVP, U.S. medical affairs at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).

Boehringer Ingelheim appointed Yew Looi Liew as president of U.S. human pharma. He was corporate SVP and head of human pharma for BI’s emerging markets region and succeeds Jean-Michel Boers, who is now president and CEO of Boehringer Ingelheim USA Corp. ...